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Abstract N-Atracotoxins are novel peptide toxins from the
venom of Australian funnel-web spiders that slow sodium current
inactivation in a similar manner to scorpion K-toxins. To analyse
their interaction with known sodium channel neurotoxin receptor
sites we determined their effect on scorpion toxin, batrachotoxin
and saxitoxin binding. Nanomolar concentrations of N-atraco-
toxin-Hv1 and N-atracotoxin-Ar1 completely inhibited the
binding of the scorpion K-toxin AaH II to rat brain synapto-
somes as well as the binding of LqhKIT, a scorpion K-toxin
highly active on insects, to cockroach neuronal membranes.
Moreover, N-atracotoxin-Hv1 cooperatively enhanced batracho-
toxin binding to rat brain synaptosomes in an analogous fashion
to scorpion K-toxins. Thus the N-atracotoxins represent a new
class of toxins which bind to both mammalian and insect sodium
channels at sites similar to, or partially overlapping with, the
receptor binding sites of scorpion K-toxins.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Australian funnel-web spiders (Araneae: Hexathelidae:
Atracinae) belong to the infraorder Mygalomorphae and are
found mainly along the southeastern seaboard of Australia.
More than 30 species of funnel-web spiders have so far been
identi¢ed but it would appear that the male Sydney funnel-
web spider Atrax robustus Cambridge has been solely respon-
sible for the 14 human fatalities recorded since 1927 [1]. In-
terestingly, however, non-primates do not appear to exhibit
symptoms following envenomation due to the presence of in-
activating IgG antibodies in their plasma [2]. A variety of
peptide neurotoxins have been isolated from the venom of
this, and other, funnel-web spiders including calcium channel
blockers which target insects [3] and more recently potassium
channel blockers [4]. However, the toxin responsible for the
major primate-speci¢c symptoms of envenomation, N-atraco-
toxin-Ar1 [5], has been recently shown to target the voltage-
gated sodium channel. Both N-atracotoxin-Ar1 and its homo-
logue N-atracotoxin-Hv1 [6], from Hadronyche versuta (Rain-
bow), act in rat dorsal root ganglion neurons by slowing
tetrodotoxin-sensitive sodium current inactivation [7,8], an ac-
tion similar to polypeptide scorpion K-toxins and sea ane-
mone toxins [9,10].
N-Atracotoxin-Ar1 and N-atracotoxin-Hv1 are peptide neu-
rotoxins consisting of a single chain of 42 amino acid resi-
dues; they are highly homologous with only two non-con-
served substitutions (Fig. 1E). Both toxins have a high
proportion of basic residues and appear to be tightly folded
molecules cross-linked by four conserved intramolecular disul-
¢de bonds, including unblocked N- and C-terminal cysteines.
These toxins show no signi¢cant sequence homology with any
presently known neurotoxins, but have a similar cysteine mo-
tif to other spider neurotoxins. Recently, the solution struc-
tures for N-atracotoxin-Ar1 [11] and N-atracotoxin-Hv1 [12]
have been determined using NMR spectroscopy. Both display
a small triple-stranded antiparallel L-sheet and a disul¢de
bonding pattern which places them in a class of peptides
with an ‘inhibitor cystine knot’ motif including a number of
other animal and plant toxins and protease inhibitors [13].
Interestingly the three-dimensional fold of these toxins is com-
pletely di¡erent to the previously determined structures for
the scorpion K-toxins AaH II [14] and LqhKIT [15] and the
sea anemone toxin anthopleurin-B [16], despite similar appa-
rent actions on sodium current inactivation [9,10,17].
A variety of neurotoxins target di¡erent receptor sites on
the voltage-gated sodium channel, leading to the character-
isation of at least seven orphan receptors, referred to as neu-
rotoxin receptor sites 1^7 ([18,19]; for a review see [20,21]).
The polypeptide scorpion K-toxins and sea anemone toxins
bind to neurotoxin receptor site 3 on the extracellular surface
of the sodium channel (reviewed in [21]). This receptor site has
been shown to have complex allosteric interactions with neu-
rotoxin receptor site 2 which binds several alkaloid toxins
including batrachotoxin (reviewed in [21]). Alkaloid toxins
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induce persistent activation of sodium channels by shifting the
voltage-dependence of activation to very negative membrane
potentials and inhibiting channel inactivation [22,23]. Scor-
pion K-toxins were shown to cooperatively enhance the e¡ect
of alkaloid toxins by increasing their binding a⁄nity and ac-
tivity [24,25].
Given the similarity between the actions of N-atracotoxins
and scorpion K-toxins the aim of the present study was to
determine the likely receptor site of N-atracotoxins and their
interactions with other known neurotoxin receptor binding
sites on the voltage-gated sodium channel. The study also
aimed to determine whether N-atracotoxins, like scorpion
K-toxins, display a di¡erential phyla-speci¢c interaction with
insects or mammalian sodium channels [26]. Here we describe
that N-atracotoxins interact with nanomolar a⁄nities with the
scorpion K-toxin receptor binding site in both whole rat brain
synaptosomes and cockroach neuronal membranes, and dis-
play a classical positive allosteric interaction with neurotoxin
receptor site 2. As such they represent a new class of toxins
interacting with neurotoxin receptor site 3.
2. Materials and methods
2.1. Puri¢cation of toxins
Colonies of male Atrax robustus and female Hadronyche versuta
spiders were ‘milked’ by direct aspiration from the chelicerae of live
spiders using glass pipettes. Collected crude venom was £ushed from
pipettes using 0.1% (v/v) TFA and initial fractionation performed via
RP-HPLC using a Vydac semi-preparative column (C18, 10.4U250
mm, 15 Wm) on a Waters HPLC system. Elution of venom compo-
nents was performed using a linear gradient of 0^60% acetonitrile/
0.1% TFA over 36 min with a £ow rate of 4 ml/min. Fractions con-
taining N-atracotoxins were lyophilised then resuspended in 25% ace-
tonitrile/0.1% TFA in preparation for further puri¢cation on a Vydac
analytical column (C18, 4.6U250 mm, 5 Wm). N-Atracotoxins were
eluted from the analytical column using a linear gradient of 25^50%
acetonitrile/0.1% TFA over 30 min at a £ow rate of 1 ml/min. Purity
of eluted toxins was con¢rmed by both SDS-PAGE under reducing
and alkylating conditions with a Tris/tricine bu¡er system and by
sequencing on an Applied Biosystems Model 470A Gas Phase Se-
quencer using automated Edman degradation. Protein content was
determined using amino acid composition analysis. Toxins were
stored lyophilised at 320‡C until required, at which time they were
dissolved in 20 mM HEPES-Tris (pH 6.0, 4‡C). AaH II was puri¢ed
according to the methods of Miranda et al. [27]. LqhKIT was a gen-
erous gift from Professor Eliahu Zlotkin (The Hebrew University of
Jerusalem, Jerusalem, Israel) and was puri¢ed as described by Eitan et
al. [17].
2.2. Toxicity assays
Mammalian toxicity of N-atracotoxin-Hv1 was determined by intra-
cerebroventricular (i.c.v.) and subcutaneous (s.c.) injection of increas-
ing amounts of toxin in 0.1^0.2 ml saline into adult male mice (strain
C57BL/6, 20 þ 2 g). Lethality tests were conducted with a minimum
number of animals and the development of toxicity monitored over
24 h. Insect toxicity was determined by microinjection of N-atracotox-
in-Hv1 using a microapplicator (Burkard, Herts, UK) ¢tted with a
29-gauge hypodermic needle. Paralysis and lethality were determined
by lateroventral thoracic injection into 4th instar crickets (Gryllus sp.,
70 þ 15 mg body weight) or ventroposterior intersegmental injection
into 5- or 6-day-old sheep blow£y larvae (Lucilia cuprina, 65 þ 10 mg
body weight). N-Atracotoxin-Hv1 was dissolved in insect saline of the
following composition (in mM): NaCl 200, KCl 3.1, CaCl2 5.4,
MgCl2 5, NaHCO3 2, NaH2PO4 0.1, pH 7.2. Insects, 10 or 12 per
group, were injected with 8 concentrations of N-atracotoxin-Hv1. A
positive result was scored when a characteristic paralysis (contraction
and immobilisation) was observed. The median paralytic dose (PD50)
was de¢ned as the dose that paralyses 50% of insects within 30 min
whilst the LD50 is the dose that kills 50% of crickets within 72 h of
injection.
2.3. Neuronal membrane preparation
Synaptosomes for 125I-AaH II, [3H]STX and [3H]BTX binding as-
says were prepared from brains of male Wistar rats (4^8 weeks, 250^
350 g) using a combination of homogenisation and di¡erential and
density gradient centrifugation according to the method described by
Tamkun and Catterall [28]. Synaptosomes were suspended in a solu-
tion consisting of (in mM): choline chloride 130, KCl 5.4, MgSO4 0.8,
D-glucose 5.5, and HEPES-Tris 50 (pH 7.4, 37‡C). The protein con-
centration of the ¢nal synaptosome suspension was determined ac-
cording to the method of Peterson [29] using BSA as a standard.
Insect synaptosomes (P2L preparation) were prepared from the cen-
tral nervous system of adult American cockroaches (Periplaneta amer-
icana) according to the methods described by Gordon et al. [30] and
Moskowitz et al. [31]. A combination of protease inhibitors consisting
of phenylmethylsulfonyl £uoride (50 Wg/ml), pepstatin A (1 WM), io-
doacetamide (1 mM), and 1,10-phenanthroline (1 mM) was present in
all bu¡ers used for this procedure. Cockroach neuronal membrane
protein concentration was determined using a Bio-Rad protein assay
with BSA as a standard.
2.4. Binding assays
Equilibrium competition assays were performed using increasing
concentrations of the unlabelled toxin in the presence of a constant
low concentration of the radiolabelled toxin. Equilibrium competition
experiments with 125I-scorpion toxins were analysed by the iterative
computer program LIGAND, using ‘Drug’ analysis (Elsevier Biosoft,
UK). Standard binding medium composition was (in mM): choline
chloride 130, CaCl2 1.8, KCl 5.4, MgSO4 0.8, D-glucose 5.5, HEPES
50, pH 7.4, BSA 1 mg/ml. Standard wash bu¡er composition was (in
mM): choline chloride 163, CaCl2 1.8, KCl 5.4, MgSO4 0.8, HEPES
5, pH 7.4, BSA 1 mg/ml. The binding medium composition for 125I-
LqhKIT binding was (in mM): choline chloride 140, CaCl2 1.8, KCl
5.4, MgSO4 0.8, D-glucose 10, HEPES 25, pH 7.4, BSA 2 mg/ml. The
wash bu¡er composition for 125I-LqhKIT binding was (in mM): chol-
ine chloride 140, CaCl2 1.8, KCl 5.4, MgSO4 0.8, HEPES 25, pH 7.4,
BSA 5 mg/ml. After incubation the reaction was terminated by dilu-
tion with 4 ml of ice-cold wash solution for [3H]STX, [3H]BTX and
125I-AaH II binding experiments or 2 ml of ice-cold wash solution for
125I-LqhKIT binding experiments. Separation of free from bound tox-
in was achieved by rapid ¢ltration under vacuum using Whatman
GF/C ¢lters, except for [3H]STX binding which used Whatman
GF/B ¢lters (Crown Scienti¢c, Australia). The ¢lter discs were washed
with a further 2U4 ml of wash solution for [3H]STX, [3H]BTX and
125I-AaH II binding or 2U2 ml washes for 125I-LqhKIT binding.
AaH II was radioiodinated by lactoperoxidase as described previ-
ously [32] using 1 nmol of toxin and 1 mCi of carrier-free Na125I
(Australian Radioisotopes, ANSTO, Lucas Heights, N.S.W., Austra-
lia). 125I-AaH II was puri¢ed by suspension with AG 1U8 (50^100
mesh) anion exchange resin (Bio-Rad, Hercules, CA, USA) according
to the methods of Teitelbaum et al. [33]. Competition binding experi-
ments using 125I-AaH II were performed according to a variation of
the method described by CesteØle et al. [34]. Brie£y, rat brain synapto-
somes (150 Wg protein/ml) were suspended in 200 Wl of binding bu¡er
containing 0.5 nM 125I-AaH II. After incubation for 30 min at 37‡C
the reaction was terminated by rapid ¢ltration. Non-speci¢c toxin
binding was determined in the presence of 300 nM AaH II and was
typically 25^30% of total binding.
LqhKIT was iodinated using IODO-GEN (Pierce) using 0.7 nmol of
toxin and 0.5 mCi of carrier-free Na125I as described by Gordon and
Zlotkin [35]. The monoiodotoxin was puri¢ed via RP-HPLC using a
Merck analytical C8 column and a linear gradient of 5^90% acetoni-
trile/0.1% TFA at a £ow rate of 1 ml/min, as previously described [34].
The concentration of the radiolabeled toxins was determined accord-
ing to the speci¢c activity of the 125I corresponding to 4200^3450
dpm/fmol monoiodotoxin, depending on the time of use (the age of
the iodine). Competition binding experiments using 125I-LqhKIT were
performed according to the methods of Gordon et al. [36]. Brie£y,
insect synaptosomes (P2L, 3.3 Wg protein/ml) were suspended in 0.3 ml
of binding bu¡er containing 30 pM 125I-LqhKIT. After incubation for
60 min at 22‡C the reaction was terminated by ¢ltration. Non-speci¢c
toxin binding was determined in the presence of 1 WM LqhKIT and
was typically 1% of total binding.
[3H]BTX binding experiments were performed according to a mod-
i¢cation of the method described by Catterall and colleagues [37]. Rat
brain synaptosomes (350 Wg protein/ml) were suspended in 0.2 ml
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bu¡er, containing 15 nM [3H]BTX (0.8 WCi; DuPont, Boston, MA,
USA). After incubation for 50 min at 37‡C, the reaction was termi-
nated by rapid ¢ltration. Non-speci¢c binding was determined in the
presence of 300 WM veratridine (Sigma Aldrich, St. Louis, MO, USA)
and was typically 5^10% of total binding.
[3H]STX binding assays were performed using the method previ-
ously described by Catterall and colleagues [38]. Rat brain synapto-
somes (300 Wg) and 2 nM [3H]STX (0.2 WCi; Amersham, Little Chal-
font, Buckinghamshire, UK) were incubated for 30 min at 37‡C
followed by ¢ltration. Non-speci¢c binding was determined in the
presence of 1 WM tetrodotoxin (Calbiochem, Alexandria, N.S.W.,
Australia) and was typically 5^15% of total binding.
2.5. Data analysis
The PD50 and LD50 values for toxicity assays and the IC50 values
for the inhibition of 125I-scorpion toxin binding were determined by
non-linear regression analysis using the Hill equation. The EC50 val-
ues for the enhancement of [3H]BTX binding were determined by
non-linear regression using the Logistic equation. All curve ¢tting
procedures used a non-linear least squares method of regression and
splining routines. Competition binding studies with 125I-AaH II and
125I-LqhKIT were analysed by the iterative computer program
LIGAND (Biosoft, UK). The IC50 values obtained for inhibition of
scorpion toxin binding were subsequently converted to Ki values ac-
cording to the relationship described by Cheng and Pruso¡ [39]. All
data are presented as mean þ standard error of the mean (S.E.). All
experiments were performed in duplicate or triplicate.
3. Results
3.1. HPLC puri¢cation of N-atracotoxins
N-Atracotoxins were puri¢ed from funnel-web spider venom
by RP-HPLC (Fig. 1). Samples were initially puri¢ed by semi-
preparative RP-HPLC column and fractions containing N-
atracotoxin-Ar1 (39% acetonitrile/0.1% TFA) and N-atraco-
toxin-Hv1 (37% acetonitrile/0.1% TFA) were pooled and
lyophilised. Crude N-atracotoxins were then further puri¢ed
by analytical RP-HPLC with N-atracotoxin-Ar1 and N-atraco-
toxin-Hv1 eluting at 46% and 44% acetonitrile/0.1% TFA,
respectively.
3.2. Inhibition of 125I-scorpion toxin binding by N-atracotoxins
Binding of scorpion toxins to neurotoxin receptor site 3 on
the sodium channel can be measured directly using 125I-la-
belled scorpion toxins [40,41]. A range of concentrations of
N-atracotoxins were incubated with 0.5 nM 125I-AaH II and
rat brain synaptosomes (Fig. 2). Both N-atracotoxins were
found to compete with 125I-AaH II binding in a concentra-
tion-dependent manner and completely inhibit its binding at
higher concentrations. The competition curves for 125I-AaH II
binding in rat brain synaptosomes reveal that N-atracotoxins
displace 125I-AaH II with IC50 values less than one order of
magnitude higher than unlabelled AaH II (Fig. 2A). The cal-
culated Ki values were 5.4 þ 1.4 nM and 4.3 þ 1.5 nM for
N-atracotoxin-Hv1 and N-atracotoxin-Ar1, respectively, as
compared with 0.8 þ 0.4 nM for unlabelled AaH II.
To assess if funnel-web spider toxins compete for the scor-
pion K-toxin site on insect sodium channels a range of con-
centrations of N-atracotoxins were incubated with 30 pM 125I-
LqhKIT and cockroach neuronal membranes. Surprisingly,
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Fig. 1. Isolation of N-atracotoxins from funnel-web spider venom. A and B: Semi-preparative RP-HPLC traces of whole H. versuta (A) and A.
robustus venom (B). The arrows mark the lethal fractions containing N-atracotoxin-Hv1 (a) and N-atracotoxin-Ar1 (b). C and D: Analytical
RP-HPLC chromatograms of the lethal fraction from A and B. E: Comparison of the primary structures of N-atracotoxin-Ar1 and N-atracotox-
in-Hv1. Sequences were obtained from Brown et al. [5] and Sheumack et al. [6], respectively. Identities are boxed and residues in grey at posi-
tions 11 and 37 indicate non-conserved substitutions. The disul¢de bonding pattern for both toxins, shown below the sequences, was taken
from Pallaghy et al. [11] and Fletcher et al. [12]. The ¢rst three disul¢de bonds form the inhibitory cystine knot motif (see Section 1).
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N-atracotoxin-Hv1 and N-atracotoxin-Ar1 completely dis-
placed 125I-LqhKIT binding at picomolar concentrations
(Fig. 2B). The calculated Ki values for inhibition of 125I-
LqhKIT binding were 111 þ 7 pM for N-atracotoxin-Hv1 and
171 þ 7 nM for N-atracotoxin-Ar1; under the same conditions
LqhKIT was reported to bind with a Kd of 30 pM [36].
3.3. Insect and mice bioassay
Non-primates rapidly develop resistance post partum to the
actions of N-atracotoxins, due to the production of IgG anti-
bodies [2]. Previous studies to determine the mammalian tox-
icity of N-atracotoxins were therefore performed by s.c. injec-
tion into newborn (1-day-old) mice with LD50 values of
0.22 mg/kg (4.4 Wg/20 g) for N-atracotoxin-Hv1 and 0.16
mg/kg (3.2 Wg/20 g) for N-atracotoxin-Ar1 [5,42]. However,
this may not accurately re£ect the toxicity of N-atracotoxin
to mammals since there may already be appreciable expres-
sion of this plasma inactivating factor in neonatal animals.
Accordingly, intracerebroventricular and subcutaneous injec-
tions were performed in adult mice and the LD50 of N-atraco-
toxin-Hv1 determined to be 1.2 ng/20 g as compared with
4 Wg/20 g via subcutaneous injection. This extremely low
mammalian LD50, via the intracerebroventricular route, is
comparable to that of AaH II (see Table 1). However, the
LD50 via the subcutaneous route is markedly higher for
N-atracotoxin-Hv1 than for AaH II re£ecting inactivation of
the toxin by plasma IgG antibodies [2], which probably do
not cross the blood-brain barrier.
As predicted from the inhibition of binding of the scorpion
K-toxin highly active on insects, 125I-LqhKIT, N-atracotoxin-
Hv1 also showed neurotoxicity in insects observed as a de-
layed contractile paralysis of blow£y larvae and crickets. The
PD50 for N-atracotoxin-Hv1, determined after 30 min, was
200 þ 36 pmol/g in crickets and 54 þ 14 pmol/g in blow£y lar-
vae (n = 3). Curiously, however, the crickets tended to recover
from this paralysis with the rate of onset and duration of the
paralytic contraction being dose-dependent. At the PD50, con-
tractile paralysis commenced within 30 min but crickets
mostly recovered over the next 24 h. At higher concentrations
contractile paralysis was immediate eventually leading to
death 2^4 days later. The LD50 of N-atracotoxin-Hv1 in crick-
ets after 72 h was 770 þ 87 pmol/g (n = 3). The nearly four-fold
higher LD50 as compared to the PD50 re£ects this recovery
from the contractile paralysis. These symptoms are in contrast
to excitatory insect toxins from scorpion venom, such as AaIT
[43], which produce an immediate and transient contractile
paralysis of blow£y larvae, but are similar to those reported
for LqhKIT [17].
3.4. Enhancement of [3H]BTX binding by N-atracotoxin-Hv1
Since scorpion K-toxins act in a cooperative manner to
allosterically enhance the binding of site 2 alkaloid toxins
[35,46] we examined whether N-atracotoxin-Hv1 could en-
hance [3H]BTX binding to rat brain synaptosomes. N-Atraco-
toxin-Hv1 was found to produce a 12-fold increase in
[3H]BTX binding, with an EC50 of 25.2 þ 4.5 nM (n = 4). In
comparison, AaH II-enhanced [3H]BTX binding under the
same conditions gave a 5.6-fold enhancement with an EC50
of 14.5 þ 2.3 nM (Fig. 3). In order to test whether the en-
hancement of [3H]BTX binding represents an increase in bind-
ing to neurotoxin receptor site 2, N-atracotoxin-Hv1-enhanced
[3H]BTX binding was measured in the presence of increasing
concentrations of unlabelled batrachotoxin and veratridine.
Both alkaloid toxins were able to completely inhibit [3H]BTX
binding enhanced by 3 WM N-atracotoxin-Hv1 in a concentra-
tion-dependent manner (data not shown).
3.5. E¡ect of N-atracotoxin-Hv1 on [3H]STX binding
Tetrodotoxin, saxitoxin and W-conotoxins can inhibit ion
movement through the pore of the voltage-gated sodium
channel by binding to neurotoxin receptor site 1 at the mouth
of the channel [47^49]. N-Atracotoxins have been reported to
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Fig. 2. Inhibition of scorpion toxin binding by N-atracotoxins. A:
Inhibition of 125I-AaH II binding N-atracotoxins in rat brain synap-
tosomes. A range of concentrations of N-atracotoxin-Hv1 (b),
N-atracotoxin-Ar1 (a) and AaH II (inset) were incubated with
150 Wg rat synaptosomes and 0.5 nM 125I-AaH II for 30 min at
37‡C. Data have been presented as a percentage of maximal 125I-
AaH II following correction for non-speci¢c binding determined in
the presence of 300 nM AaH II. Values represent the mean þ S.E.
of 3 experiments. The curves were ¢tted using the Hill equation
with regression coe⁄cients (R2) higher than 0.92. The calculated
IC50 values and Hill coe⁄cients (nH) for inhibition of 125I-AaH II,
respectively, were: N-atracotoxin-Hv1, 8.2 þ 2.1 nM, 1.07 þ 0.23;
N-atracotoxin-Ar1, 6.5 þ 2.3 nM, 0.82 þ 0.21; AaH II, 1.2 þ 0.6 nM,
0.79 þ 0.26. B: Inhibition of 125I-LqhKIT binding by N-atracotoxins
in cockroach neuronal membranes. A range of concentrations of
N-atracotoxin-Hv1 (b) and N-atracotoxin-Ar1 (a) were incubated
with 1 Wg P. americana neuronal membranes and 0.03 nM 125I-
LqhKIT for 60 min at 22‡C. Data have been presented as a percent-
age of maximal 125I-LqhKIT binding following correction for non-
speci¢c binding determined in the presence of 1 WM LqhKIT. Values
represent the mean þ S.E. of 3 experiments. The curves were ¢tted
using the Hill equation with regression coe⁄cients (R2) higher than
0.987. The calculated IC50 values and Hill coe⁄cients (nH) for inhi-
bition of 125I-LqhKIT, respectively, were: N-atracotoxin-Hv1, 333 þ
21 pM, 1.22 þ 0.10; N-atracotoxin-Ar1, 514 þ 21 pM, 1.13 þ 0.05.
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reduce TTX-sensitive sodium currents in rat dorsal root gan-
glion neurons in a dose-dependent manner [7,8]. In order to
determine whether N-atracotoxin-Hv1 inhibits tetrodotoxin-
sensitive sodium currents through an interaction with receptor
site 1 of the channel, a range of concentrations of N-atraco-
toxin-Hv1 were incubated with rat brain synaptosomes in the
presence of 2 nM [3H]STX. N-Atracotoxin-Hv1 was unable to
signi¢cantly decrease [3H]STX binding, even at concentrations
as high as 3 WM (Fig. 3, inset). This indicates that the reduc-
tion in peak sodium current in dorsal root ganglion neurons
produced by N-atracotoxins is not due to an interaction with
receptor site 1.
4. Discussion
Similar to scorpion K-toxins, N-atracotoxins are polypeptide
neurotoxins that slow sodium current inactivation [7^9]. Giv-
en these comparable actions on sodium channel gating ki-
netics, the present study investigated the interaction of N-atra-
cotoxins with scorpion toxin binding. We have shown that
N-atracotoxins compete at nanomolar concentrations for the
binding of the ‘classical’ scorpion K-toxin AaH II to neuro-
toxin receptor site 3 on rat brain sodium channels. N-Atraco-
toxins also enhanced the binding of the site 2 alkaloid toxin
[3H]BTX in a positive allosteric manner (Fig. 3), an action
analogous to scorpion K-toxins [20]. An unexpected ¢nding
of the present study, however, was that N-atracotoxins also
inhibited the binding of the scorpion K-insect toxin LqhKIT
to cockroach neuronal membranes. This ¢nding was sup-
ported by toxicity tests in insects which revealed that N-atra-
cotoxin-Hv1 produced a delayed contractile paralysis but the
LD50 was relatively higher in comparison with other insect-
selective scorpion toxins despite a potent inhibition of 125I-
LqhKIT binding. Thus N-atracotoxins appear to represent a
new class of toxins which interact with neurotoxin receptor
site 3, but unlike scorpion K-toxins, are able to potently in-
teract with insect sodium channels.
Despite all slowing sodium channel inactivation, scorpion
K-toxins are a heterogenous class comprising several di¡erent
groups determined by their phyla-speci¢c activity on mam-
mals and insects as well as their binding properties. The ¢rst
group comprises the ‘classical’ K-toxins, such as AaH II and
Lqq V; highly active on mammals but weakly toxic to insects.
The second group are the K-toxins highly active on insects
(here de¢ned as K-insect toxins) such as LqhKIT and Lqq
III; highly toxic to insects but weakly active on mice. The
third group are the ‘K-like’ that are active on mammals but
do not compete with classical K-toxins for binding to rat brain
synaptosomes (see Fig. 4). Those that have been characterised,
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Fig. 3. E¡ect of N-atracotoxin-Hv1 on [3H]BTX and [3H]STX bind-
ing. Main panel: Enhancement of [3H]BTX by N-atracotoxin-Hv1
and AaH II. A range of concentrations of AaH II (a) and N-atraco-
toxin-Hv1 (b) were incubated with 350 Wg protein and 15 nM
[3H]BTX at 37‡C for 50 min. Data are presented as fmol of
[3H]BTX bound per mg of synaptosomal protein following correc-
tion for non-speci¢c binding determined in the presence of 300 WM
veratridine. Values represent the mean þ S.E. of 4 experiments. In-
set: No alteration in [3H]STX binding by N-atracotoxin-Hv1. A
range of concentrations of N-atracotoxin-Hv1 were incubated with
rat brain synaptosomes in the presence of 2 nM [3H]STX at 37‡C
for 30 min. Data are presented as the percentage of maximal
[3H]STX binding following correction for non-speci¢c binding deter-
mined in the presence of 1 WM TTX. The dashed line represents
[3H]STX binding in the absence of N-atracotoxin-Hv1. Values repre-
sent the mean þ S.E. of 5 experiments.
Table 1
Toxicity of N-atracotoxin and scorpion toxins to mammals and insects











N-Atracotoxin-Hv1 N-Atracotoxin 1.2 4 770 3420 0.004
AaH I K-Toxins 10b 0.35b 276e 35 0.181
AaH II 0.5b 0.24b 897e 480 0.003
AaH III 7b 0.5b 1490e 71 0.024
Lqq IV 27b 1.4b 1230e 52 0.110
Lqq V 2.5b 0.5b 2317e 200 0.005
LqhKIT K-Toxins highly active on insects 1100c 1.2b 2.5e 1.1 2200
Lqq III 1100d 1.1d 8.3d 1.0 662.7
Bom III K-Like toxins 23b 3.0b 52.6e 130 2.186
Bom IV 23e 5.5b 19.7e 239 5.838
aRelative toxicity ratio = (LD50 mice (i.c.v.)/LD50 AaH II (i.c.v.))/(LD50 insect/LD50 LqhKIT).
bMartin-Eauclaire et al. [50].
cKopeyan and Gordon, unpublished.
dKopeyan et al. [55].
eGordon et al. [36].
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such as Bom III, Bom IV and Lqh III are also active on
insects ([36,51]; for review see [52]). In the present study com-
petition binding experiments revealed that N-atracotoxins were
able to completely displace both AaH II and LqhKIT binding
with less than a 50-fold di¡erence in Ki values. The ability to
potently inhibit both scorpion K-toxin and K-insect toxin
binding with such high a⁄nities on both mammals and insects
(see Fig. 4) clearly sets N-atracotoxins apart from other scor-
pion and sea anemone toxins. Thus, N-atracotoxins represent a
novel group of neurotoxins which compete for binding with
neurotoxin receptor site 3 on voltage-gated sodium channels.
Earlier studies using whole venom revealed strong insectici-
dal activity [44], which was generally thought to reside in
fractions such as the g-atracotoxin class of toxins [3]. These
toxins produce a slow paralysis in cockroaches leading to
death in 1^2 days (J. Fletcher, personal communication). Giv-
en the high content of N-atracotoxins in the venoms on funnel-
web spiders (up to 10% with N-atracotoxin-Ar1) [45] this may
also contribute signi¢cantly to the rapid paralysis of target
insects.
Despite competitive interactions with neurotoxin receptor
site 3 (Figs. 2 and 3), and positive allosteric interactions
with neurotoxin receptor site 2 (Fig. 3), the actual binding
interactions with the channel may di¡er, at least partially,
between N-atracotoxins and scorpion K-toxins. The main dif-
ference is that N-atracotoxins reduce peak sodium currents in
rat dorsal root ganglion neurons whilst scorpion K-toxins in-
crease or fail to alter sodium currents [7^9]. This decrease in
peak current was not the result of an interaction with neuro-
toxin receptor site 1 since N-atracotoxins failed to alter
[3H]STX binding to rat brain synaptosomes (Fig. 3, inset).
This may therefore be a result of a reduction in single channel
conductance in addition to a slowing of inactivation or a
block of the channel distant from receptor site 1. Determina-
tion of the mechanism of this reduction in sodium channel
conductance will have to await single channel analysis of N-
atracotoxin-modi¢ed sodium currents.
N-Atracotoxins and scorpion K-toxins therefore appear to
bind to partially overlapping sites on the sodium channel lo-
calised within the area of receptor site 3. In support of this
contention, the N-atracotoxin receptor site, like site 3, is on the
extracellular side of the channel since intracellular application
of funnel-web spider toxins does not alter sodium channel
gating or kinetics [7,8]. In addition, the ‘K-like’ toxins, that
also inhibit sodium current inactivation, were suggested to
bind to a partially overlapping receptor site with scorpion
K-toxins and sea anemone toxins [36].
Recently the mutagenesis study of Rogers et al. [53] has
identi¢ed a number of residues in the S3^S4 short extracellu-
lar loop of Domain IV of the sodium channel K-subunit crit-
ical for the binding of scorpion K-toxins and sea anemone
toxins. These residues were found to include cationic and
anionic residues suggested to be important for the binding
of scorpion K-toxin and sea anemone toxins. Fletcher et al.
[12] have investigated whether N-atracotoxin-Hv1, and other
site 3 neurotoxins, share topologically related charged residues
that might interact with complementary charged residues in
the S3^S4 loop. They found that three cationic and two
anionic residues in N-atracotoxin-Hv1 can be superimposed
on the structures of anthopleurin-B and AaH II including
those suggested to be important for binding, despite their
lack of sequence homology and totally di¡erent three-dimen-
sional folds. Since N-atracotoxins compete for LqhKIT bind-
ing we also assessed if N-atracotoxins share topologically re-
lated amino acids with those critical for the binding of
LqhKIT [54]. Despite their completely di¡erent three-dimen-
sional folds the structure of N-atracotoxin-Hv1 (pdb accession
code 1vtx) and LqhKIT (pdb accession code 1lqi) can be over-
laid in such a way that residues Lys4, Arg5 and Lys19 in
N-atracotoxin-Hv1 superimpose very closely on residues
Arg64, Lys62 and Lys8 in LqhKIT. Interestingly, these residues
are di¡erent to those which superimpose on the structures of
AaH II and anthopleurin-B [12].
In summary, the N-atracotoxins bind to a similar cluster of
receptor sites as scorpion K-toxins. Despite the slowing of
sodium current inactivation and the competition for scorpion
K-toxin binding di¡erences amongst these receptor sites are
indicated by the inhibition of peak sodium current induced
by N-atracotoxins in contrast to the usual increase obtained
with scorpion K-toxins. Given that N-atracotoxins target both
mammalian and insect sodium channels there is considerable
potential as a tool to aid in the investigation of structural
requirements for anti-insect versus anti-mammal activity.
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